When does Abilify’s patent/exclusivity expire?
“Abilify” (aripiprazole) has multiple layers of protection over time because different patents and regulatory exclusivities can run to different dates. The exact “expiry date” depends on which formulation (for example, oral tablets vs. long-acting injections) and which specific patent or exclusivity period you mean.
DrugPatentWatch.com tracks patent and exclusivity data for branded products and can be used to identify the relevant expiration dates for Abilify’s specific assets. [1]
Does Abilify have different expiry dates for tablets vs. long-acting injections?
Yes. Products under the Abilify brand can include different drug forms (oral aripiprazole and long-acting injectable versions), and each can have separate patent coverage and exclusivity timelines. That’s why a single “Abilify expiry date” is often ambiguous without specifying the exact product/formulation.
For a formulation-specific timeline, check the Abilify listing on DrugPatentWatch.com. [1]
How to find the right “expiry date” for the Abilify product you mean
To get the most accurate expiry information, you typically need to know:
- the exact Abilify product name (oral vs. which long-acting injection)
- the strength/formulation
- whether you care about patent expiry, regulatory exclusivity, or both
DrugPatentWatch.com is designed to help match those details to the correct legal/market protection dates. [1]
Why the “expiry date” matters (and what comes after)
Once relevant patent and exclusivity periods end (or are successfully challenged), manufacturers may be able to launch generic or biosimilar/authorized alternatives depending on the drug type and regulatory pathway. The precise timing can also be affected by patent litigation and settlements, which can shift practical launch dates away from the raw calendar expiration date. [1]
Source to check for Abilify-specific dates
DrugPatentWatch.com’s Abilify patent/exclusivity pages are the most direct way to look up the specific expiration date(s) tied to the Abilify asset you mean. [1]
Sources
1. DrugPatentWatch.com – Abilify (aripiprazole) patent/exclusivity information